Dr. Ratnesh Chopra M.D.

Recommended Articles

• The History of Fibromyalgia

  IntroductionSome may consider fibromyalgia as a fairly new medical condition, but the truth is, this medical condition has actually existed for more than centuries. The term “fibromyalgia” first came into existence in the year 1976. Since the early 1800s, scientists and physicians have written...

• Rheumatoid Arthritis Market Projected to Skyrocket

  Rheumatoid arthritis is the most common form of autoimmune arthritis. It is estimated to affect around 5 million people, and anyone can develop the disease; but it is most common among middle aged women. Although men, children and young adults can also get it. Genes, environment, and hormones are...

• 9-Year Study Determines Genes Associated with Lupus

  Scientists are now closer than ever to a breakthrough in researching the cause behind lupus which in turn, could lead to more investigation into faster, more focused and accurate methods of diagnosing this autoimmune disease. Consequently, this could also lead to the creation more effective...

• Pregnancy and Motherhood with Fibromyalgia

  Motherhood is one of the most rewarding experiences a woman has the opportunity to experience.  It brings with it challenges, and it can truly shape a mother into who she ends up being for the rest of her life. The act of giving birth is one of the most natural and beautiful events that happen...

• Seeking Online Resources for Fibromyalgia Information

  For those who have had fibromyalgia disease for 20 years or even more, the internet has offered a lot of information online and this information can be found with ease. For those young people who don’t understand the world without internet, finding information about the disease or anything to help...

• Health Canada Gives Approval on AVACEN 100 for Fibromyalgia Treatment

  Health Canada, which is a federal department in charge of assisting Canadians with obtaining quality healthcare and promoting healthy lifestyle practices, just gave its approval for the licensing of the AVACEN 100 Class II to be used in the treatment of fibromyalgia, which afflicts about 10 million...